Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Lancet Psychiatry. 2023 Jun;10(6):441–451. doi: 10.1016/S2215-0366(23)00143-8

Table 1.

Bidirectional Mendelian Randomization Analysis

Exposure Outcome Method N SNPs Estimate OR SE P PFDR
LCU SCZ Inverse variance weighted 4 β= 0.16 1.17 0.14 0.23 3.13e-1
MR Egger 4 β= −0.96 0.38 0.88 0.39 4.74e-1
Weighted Median 4 β= 0.23 1.26 0.11 0.03 5.37e-2
MR-PRESSO (raw) 4 β= 0.16 1.17 0.14 0.32 4.18e-1
CAUSE 6236335 γ= 0.05 1.05 0.05 0.61 6.48e-1

LCU BIP Inverse variance weighted 4 β= 0.37 1.45 0.13 5.37e-3 1.22e-2
MR Egger 4 β= −0.63 0.53 0.90 0.55 6.23e-1
Weighted Median 4 β= 0.40 1.49 0.11 1.78e-4 6.72e-4
MR-PRESSO (raw) 4 β= 0.37 1.45 0.13 0.07 1.19e-1
CAUSE 6994919 γ= 0.06 1.03 0.05 0.52 6.10e-1

CUD SCZ Inverse variance weighted 2 β= 0.45 1.57 0.13 6.40e-4 1.98e-3
MR Egger 2 NA NA NA NA NA
Weighted Median 2 NA NA NA NA NA
MR-PRESSO (raw) 2 NA NA NA NA NA
CAUSE 6006946 γ= 0.05 1.05 0.05 0.60 6.48e-1

CUD BIP Inverse variance weighted 2 β= 0.03 1.03 0.10 0.79 8.14e-1
MR Egger 2 NA NA NA NA NA
Weighted Median 2 NA NA NA NA NA
MR-PRESSO (raw) 2 NA NA NA NA NA
CAUSE 6358021 γ= 0.05 1.05 0.04 0.38 4.74e-1

SCZ LCU Inverse variance weighted 128 β= 0.09 1.09 0.02 7.45e-6 5.07e-5
MR Egger 128 β= −0.02 0.98 0.09 8.45e-1 8.45e-1
Weighted Median 128 β= 0.11 1.12 0.02 9.69e-6 5.49e-5
MR-PRESSO (corrected) 124 β= 0.10 1.11 0.02 4.06e-7 3.45e-6
CAUSE 6236335 γ= 0.05 1.05 0.01 9.90e-3 2.10e-2

SCZ CUD Inverse variance weighted 129 β= 0.21 1.23 0.03 3.50e-12 1.19e-10
MR Egger 129 β= 0.36 1.43 0.12 4.02e-03 1.05e-2
Weighted Median 129 β= 0.21 1.23 0.04 4.97e-08 5.63e-7
MR-PRESSO (corrected) 126 β= 0.20 1.23 0.03 9.66e-12 1.64e-10
CAUSE 6006946 γ= 0.09 1.09 0.02 0.02 3.78e-02

BIP LCU Inverse variance weighted 36 β= 0.11 1.12 0.03 1.21e-4 5.14e-4
MR Egger 36 β= 0.69 1.99 0.15 7.90e-5 3.84e-4
Weighted Median 36 β= 0.12 1.13 0.04 1.91e-3 5.41e-3
MR-PRESSO (raw) 36 β= 0.11 1.12 0.03 4.89e-4 1.66e-3
CAUSE 6994919 γ= 0.07 1.07 0.02 4.60e-3 1.12e-2

BIP CUD Inverse variance weighted 38 β= 0.06 1.06 0.05 0.18 2.66e-1
MR Egger 38 β= 0.61 1.84 0.26 0.02 3.78e-2
Weighted Median 38 β= 0.10 1.11 0.07 0.13 2.01e-1
MR-PRESSO (raw) 38 β= 0.06 1.06 0.05 0.19 2.69e-1
CAUSE 6358021 γ= 0.06 1.06 0.03 0.12 1.94e-1

Note: MR-PRESSO produces the same estimates as the inverse variance weighted method when no outlier SNP estimates are detected [i.e., MR-PRESSO (raw)]. When outliers are detected, those SNPs are removed, and the inverse variance weighted estimate is re-calculated [MR-PRESSO (corrected)]. NA (not applicable) is used when the particular MR method was unable to estimate the causal effect using so few SNPs. CAUSE uses the full set of overlapping SNPs between two genome-wide association studies to estimate the causal effect. The causal effect presented is the gamma (γ) estimate from the causal model and the p-value is from a test of whether the causal model is a better fit. LCU: Lifetime cannabis use; CUD: Cannabis use disorder; SCZ: Schizophrenia, BIP: Bipolar disorder; MR: Mendelian Randomization; N SNPs: number of single nucleotide polymorphisms (genetic variants) included in the analysis; OR: Odds Ratio: SE: Standard error; p: P-value; PFDR: P-value after the Benjamini-Hochberg correction.